Researchers develop model to predict treatment response in gastric cancer
A study is validating the use of genomic sequencing to predict the likelihood that patients with gastric cancer will derive benefit from chemotherapy or from immunotherapy.
Materials provided by Mayo Clinic. Original written by Joe Dangor. Note: Content may be edited for style and length.
Source link aaaaa